The physiological actions of endogenous GLP-1, and synthetic GLP-1RAs include inhibition of gastric emptying
It suppresses smoking-addiction cravings
Nowhere, and at no point, does this accompany any discussion of body dysmorphia, nor the psychological impact that losing a massive amount of weightonly to potentially gain it backcan have on an individual
For competitive athletes there is a separate, definitive problem: WADA classifies BPC-157 as an S0 prohibited substance, meaning any in-competition or out-of-competition use is sanctionable [13]
Legal Grounds for Claims: Current litigation centers on product liability, specifically whether manufacturers failed to provide adequate warnings regarding the risks of long-term gastric motility impairment
It is unexpected that retatrutide failed to increase FOC in LA